BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), a pioneer in Botanical Synthesis technology, has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024. CEO Ilan Sobel will host virtual one-on-one meetings with institutional investors and deliver a presentation on Tuesday, September 24, 2024, at 1:00 p.m. Eastern time.
The presentation will be accessible via a live audio webcast, with registration required for conference participation. Interested media and investors are encouraged to join the online presentation at least five minutes before the start time. For more information or to schedule a meeting with management, contact MZ Group at BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pioniere nella tecnologia di sintesi botanica, è stato invitato a presentare alla iAccess Alpha Buyside Best Ideas Investor Conference il 24-25 settembre 2024. Il CEO Ilan Sobel condurrà incontri virtuali one-on-one con investitori istituzionali e farà una presentazione martedì 24 settembre 2024, alle ore 13:00, ora orientale.
La presentazione sarà accessibile tramite un webcast audio in diretta, con registrazione richiesta per la partecipazione alla conferenza. Media e investitori interessati sono invitati a partecipare alla presentazione online almeno cinque minuti prima dell'orario d'inizio. Per ulteriori informazioni o per pianificare un incontro con il management, contattare MZ Group all'indirizzo BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionero en la tecnología de síntesis botánica, ha sido invitado a presentar en la iAccess Alpha Buyside Best Ideas Investor Conference los días 24 y 25 de septiembre de 2024. El CEO Ilan Sobel llevará a cabo reuniones virtuales uno a uno con inversores institucionales y presentará el martes 24 de septiembre de 2024, a la 1:00 p.m., hora del este.
La presentación será accesible a través de un webcast de audio en vivo, con registro requerido para participar en la conferencia. Se anima a los medios interesados y a los inversores a unirse a la presentación en línea al menos cinco minutos antes de la hora de inicio. Para más información o para programar una reunión con la dirección, contacte a MZ Group en BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), 식물 합성 기술의 선구자인 이 회사는 2024년 9월 24-25일에 열리는 iAccess Alpha Buyside Best Ideas Investor Conference에 초청받았습니다. CEO Ilan Sobel은 기관 투자자와의 가상 일대일 회의를 주최하고 2024년 9월 24일 화요일 오후 1시 동부 표준시에 발표를 진행합니다.
이 발표는 실시간 오디오 웹캐스트를 통해 접근 가능하며, 컨퍼런스 참여를 위해 등록이 필요합니다. 관심 있는 언론 및 투자자들은 시작 시간 최소 5분 전에 온라인 발표에 참석할 것을 권장합니다. 추가 정보나 경영진과의 회의를 예약하려면 MZ Group에 BHSC@mzgroup.us로 연락하십시오.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionnier de la technologie de synthèse botanique, a été invité à présenter à la iAccess Alpha Buyside Best Ideas Investor Conference les 24 et 25 septembre 2024. Le PDG Ilan Sobel animera des réunions virtuelles en tête-à-tête avec des investisseurs institutionnels et présentera le mardi 24 septembre 2024, à 13h00, heure de l'Est.
La présentation sera accessible via un webcast audio en direct, avec enregistrement requis pour participer à la conférence. Les médias et investisseurs intéressés sont encouragés à rejoindre la présentation en ligne au moins cinq minutes avant l'heure de début. Pour plus d'informations ou pour planifier une réunion avec la direction, contactez MZ Group à l'adresse BHSC@mzgroup.us.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), ein Pionier in der Botanischen Synthesetechnologie, wurde eingeladen, auf der iAccess Alpha Buyside Best Ideas Investor Conference am 24. und 25. September 2024 zu präsentieren. CEO Ilan Sobel wird virtuelle Einzelgespräche mit institutionellen Investoren führen und eine Präsentation am Dienstag, den 24. September 2024, um 13:00 Uhr Eastern Time halten.
Die Präsentation wird über einen Live-Audio-Webcast zugänglich sein, wobei eine Registrierung für die Teilnahme an der Konferenz erforderlich ist. Interessierte Medienvertreter und Investoren sind eingeladen, an der Online-Präsentation mindestens fünf Minuten vor Beginn teilzunehmen. Für weitere Informationen oder um ein Treffen mit dem Management zu vereinbaren, kontaktieren Sie bitte die MZ Group unter BHSC@mzgroup.us.
- None.
- None.
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024.
CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
iAccess Alpha Buyside Best Ideas Conference
Date: Tuesday, September 24, 2024
Time: 1:00 p.m. Eastern time
Webcast: https://www.webcaster4.com/Webcast/Page/3064/51220
All interested media and investors are invited to join this online presentation. Please join at least five minutes before the start of the presentation to ensure timely participation.
A live audio webcast and archive of the presentation will be available using the webcast link above. Registration is mandatory for conference participation. For more information or to schedule a meeting with management, please contact MZ Group at BHSC@mzgroup.us.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/223089
FAQ
When is BioHarvest Sciences (CNVCF) presenting at the iAccess Alpha Buyside Best Ideas Conference?
How can investors join BioHarvest Sciences' (CNVCF) presentation at the conference?
Who will be representing BioHarvest Sciences (CNVCF) at the iAccess Alpha Buyside Best Ideas Conference?
What is the main technology BioHarvest Sciences (CNVCF) is known for?
